• HOME
  • Therapeutics
  • Technology
  • Team
  • News
  • About
  • HOME
  • Therapeutics
  • Technology
  • Team
  • News
  • About
  • V1fz3suL-

    Antimicrobial resistance is an
    increasingly serious threat to global public health

  • N1WT6iuIb

    If antibiotics lose their eFFEctiveness, key medical
    procedures could become too dangerous to perform.

  • N1PV2juIW

    An estimated 700.000 lives are lost yearly to
    anti-microbial resistant infections.
    The estimate for year 2050 is 10 million lives yearly.

  • HOME
  • News
  • Antimicrobial Peptides 2019, Gordon Research Conference

Antimicrobial Peptides 2019, Gordon Research Conference

Akthelia strongly represented at this scientific conference

January 28, 2019

The focus of the 2019 Gordon Conference on Antimicrobial Peptides is utilizing our knowledge of mechanisms of AMP action, and mining species diversity to advance application to global infection challenges, including the threat of antimicrobial resistance, and sharing experience of translating fundamental research to commercial development and clinical practice.

Akthelia is strongly represented at this conference:

  • Birgitta Agerberth, co-founder, has a með Keynote talk titled ""From the Discovery of the Cathelicidin LL-37 to Host-Directed Therapy Fighting Infections"
  • Guðmundur Hrafn Guðmundsson, co-founder, is a discussion leader in a session on "Exploiting Mechanistic Knowledge to Utilize Immunomodulatory Activities"
  • Rubhana Raqib from the International Centre for Diarrhoeal Disease Research, a long-time collaborator of Akthelia's founders has a presentation on "Induction of Antimicrobial Host Defense Peptides as a Therapeutic Strategy Against Tuberculosis"
  • And finally, Iwona T. Myszor from the Biomedical Center at the University of Iceland has a poster presentation showing how Akthelia's compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity

More information about the conference here.

Eldri fréttir

  • New substances are treating infections by activating the immune system
    January 15, 2019
  • AKTHELIA SELECTED AS FINALIST FOR THE SCIENCE 2 STARTUP EVENT
    February 27, 2018
  • NEW ARTICLE ON TREATING CHOLERA WITH ONE OF THE APD'S
    June 15, 2017
  • MORGUNBLAÐIÐ, 20/10 2017
    November 15, 2017
  • A CLINICAL TRIAL SHOWS THAT ONE OF AKTHELIA’S ACTIVES SPEEDS RECOVERY OF TUBERCULOSIS.
    June 22, 2016
  • STEFAN JÖKULL SVEINSSON JOINS AKTHELIA’S BOARD
    June 22, 2016
  • AKTHELIA APPLIES FOR PATENT FOR A NEW CLASS OF CHEMICALS
    June 1, 2016
  • JÓN INGI BENEDIKTSSON JOINS AKTHELIA AS GENERAL MANAGER
    June 22, 2016
  • MEMBERS OF AKTHELIA MANAGEMENT PLAY MAJOR ROLES AT ANTIBACTERIAL CONFERENCE.
    October 10, 2009

AKTHELIA

  • Grandagarði 16, 101 Reykjavik
  • akthelia@akthelia,is
  • 610502-6440
  • Twitter
© 2021 AKTHELIA